Skip to main content
AI Market Summary
Loading market intelligence...

Nuvasive Inc (NUVA) Stock Forecast 2025 - AI Price Prediction & Analysis


Nuvasive Inc (NUVA) AI Stock Price Forecast & Investment Analysis

Nuvasive Inc Stock Price Chart and Technical Analysis

Loading Nuvasive Inc interactive price chart and technical analysis...

Nuvasive Inc (NUVA) - Comprehensive Stock Analysis & Investment Research

Deep dive into Nuvasive Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Nuvasive Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Nuvasive Inc: Nuvasive Inc operates in the Manufacturing sector, establishing it as a mid-cap growth opportunity.

Nuvasive Inc (Stock Symbol: NUVA) is a leading company in the Manufacturing sector , specifically operating within the Surgical and Medical Instrument Manufacturing industry.

The organization employs approximately 2800 professionals worldwide and operates under the strategic leadership of CEO J. Christopher Barry.

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Nuvasive Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Nuvasive Inc: With $260M in annual revenue and 11.0% net margin, the company demonstrates solid profitability.

Annual Revenue: $260 million generating a 11.0% net profit margin .

Market Capitalization: $2085 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -4.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Nuvasive Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Nuvasive Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Nuvasive Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Nuvasive Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Nuvasive Inc: Strong free cash flow generation demonstrates developing operational efficiency.

Nuvasive Inc strategically competes in the highly dynamic Surgical and Medical Instrument Manufacturing marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company demonstrates robust operational efficiency through strong free cash flow generation of $38 million annually, complemented by impressive -21.0% year-over-year cash flow growth.

The company maintains a healthy 337.3% gross margin, indicating strong pricing power and operational efficiency.

Nuvasive Inc (NUVA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Nuvasive Inc stock analysis.

Loading Nuvasive Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Nuvasive Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Nuvasive Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Nuvasive Inc: With a P/E ratio of 105.66, the market highly values future growth prospects.

P/E Ratio 105.66x
P/B Ratio 2.34x
Market Cap $2085M
EPS $0.55
Book Value/Share $17.02
Revenue/Share $23.38
FCF/Share $1.49
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Nuvasive Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Nuvasive Inc: An ROE of -4.5% indicates room for improvement in shareholder value creation.

ROE -4.5%
ROA -1.7%
ROIC -1.5%
Gross Margin 337.3%
Operating Margin 26.3%
Net Margin 11.0%
EBT Margin -2.3%
Tax Rate 73.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Nuvasive Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Nuvasive Inc: A current ratio of 3.19 indicates strong liquidity.

Current Ratio 3.19x
Quick Ratio 1.76x
D/E Ratio 1.23x
Financial Leverage 2.66x
Interest Coverage -0.5x
Working Capital $726M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Nuvasive Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Nuvasive Inc: Free cash flow of $38M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $157M
Free Cash Flow $38M
Capital Spending $-119M
OCF Growth YoY -21.0%
FCF Growth YoY -27.3%
FCF/Sales 3.3%
CapEx/Sales 10.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Nuvasive Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Nuvasive Inc: An asset turnover of 0.54x suggests room for improvement in asset utilization.

Asset Turnover 0.54x
Receivables Turnover 5.3x
Inventory Turnover 1.0x
Fixed Assets Turnover 2.9x
Days Sales Outstanding 69 days
Days Inventory 354 days
Payables Period 123 days
Cash Conversion Cycle 300 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Nuvasive Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Nuvasive Inc: With annual revenue of $260M, Nuvasive Inc demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $260M
Operating Income $68M
Net Income $28M
R&D Expense $103M
SG&A Expense $54M
Cost of Goods Sold $348M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 37%
Cash & Short-term Investments 10%
Total Liabilities 62%
Short-term Debt 24%
Accounts Receivable 11%
Inventory 15%
Dividend & Shareholder Information
Shares Outstanding 52M
Growth Metrics (YoY)
EPS Growth 1.4%

Latest Nuvasive Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Nuvasive Inc (NUVA) stock price and investment outlook.

, source: Yahoo Finance

It's important for investors to understand why NuVasive missed analysts' earnings targets. The company made a calculated decision to ramp up spending. Research and development expenses increased 20% ...

, source: Yahoo Finance

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will ...

, source: Seeking Alpha

Greetings and welcome to the NuVasive Incorporated Second Quarter 2008 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will ...

, source: AOL

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...

, source: Seeking Alpha

Good day, ladies and gentlemen, and welcome to the NuVasive Fourth Quarter and Full Year 2022 Earnings Conference Call. I would now like to introduce your host for today's call, Ms. Juliet Cunningham, ...

, source: The Motley Fool

Investors cheered, as short-term pain in the first half of 2018 for NuVasive could lead to a stronger performance in the future. After posting a GAAP (generally accepted accounting principles) net ...

, source: The Motley Fool

NuVasive delivered better-than-expected top- and bottom-line results in the second quarter. Why it's happening: Sales of NuVasive's minimally invasive spinal surgery products grew 6.4% year-over-year ...

, source: AOL

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...

, source: Nasdaq

Shares of NuVasive, Inc. (NASDAQ: NUVA) jumped 11.6% higher on Wednesday. The medical-device maker, which focuses on spine-surgery technology, announced its second-quarter earnings results after the ...

Nuvasive Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Nuvasive Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Nuvasive Inc Stock Forecast

How accurate are Nuvasive Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for NUVA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Nuvasive Inc stock price forecasts?

Our analysis considers Nuvasive Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Nuvasive Inc a good investment in 2025?

Based on our AI analysis, Nuvasive Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Nuvasive Inc forecasts updated?

Nuvasive Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Nuvasive Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Nuvasive Inc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...